HALO logo
halo search icon
HLS Therapeutics, Inc.

CA$4.64

Price Change Indicator
0.11 (2.43%)
HLS Therapeutics, Inc.
HLS · TSE

HLS Therapeutics, Inc.

Start Trading HLS for Free

CA$4.64

Price Arrow0.11 (2.43%)
20/05/2026 12:00:00 AM
All-CompaniesAll-ConsensusHALO AllRecent Earnings upgradeRecent Price downgrade
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

HLS Therapeutics, Inc. Overview

HLS Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Weak

Earnings

Very Weak

Growth

Earnings

Very Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About HLS

icon
icon

Telephone

1.647.495.9000

icon

Address

Suite 701, 10 Carlson Court, Etobicoke, ON M9W 6L2

Description

HLS Therapeutics, Inc. engages in commercializing pharmaceutical products. It specializes in central nervous system and cardiovascular markets. The company was founded by Gregory Gubitz and Gilbert Godin on June 5, 2014 and is headquartered in Etobicoke, Canada.

HLS Price Chart

Key Stats

Market Cap

CA$141.67M

PE

0.00

EV/EBITDA

8.3

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 4.22 - 5.76

Trade Value (12mth)

US$10,260.00

1 week

1.09%

1 month

-0.22%

YTD

-4.33%

1 year

-1.49%

All time high

25.92

Key Fundamentals

EPS 3 yr Growth

-45.80%

EBITDA Margin

31.90%

Operating Cashflow

$16m

Free Cash Flow Return

13.10%

ROIC

-10.30%

Interest Coverage

2.50

Quick Ratio

0.80

Other Data

Shares Outstanding (Fully Diluted)

31m

HALO Sector

Healthcare

Next Company Report Date

18-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

HLS Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock-0.85-0.62-0.39locklocklock
EPS (Fully Diluted)
 $locklocklocklock-0.85-0.62-0.39locklocklock
Growth
 %locklocklocklock-17.327.736.1locklocklock
PE
 XlocklocklocklockN/AN/AN/Alocklocklock
EV/EBITDA
 Xlocklocklocklock7.39.58.3locklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of HLS Therapeutics, Inc. (HLS:TSE)?
Halo FAQ
The current share price of HLS Therapeutics, Inc. (HLS:TSE) is CAD$4.64.
What is the 52-week high share price for HLS Therapeutics, Inc. (HLS:TSE)?
Halo FAQ
The 52-week high share price for HLS Therapeutics, Inc. (HLS:TSE) is CAD$5.76.
What is the 52-week low share price for HLS Therapeutics, Inc. (HLS:TSE)?
Halo FAQ
The 52-week low share price for HLS Therapeutics, Inc. (HLS:TSE) is CAD$4.22.
What is the dividend yield for HLS Therapeutics, Inc. (HLS:TSE)?
Halo FAQ
HLS Therapeutics, Inc. (HLS:TSE) does not pay a dividend.
What was HLS Therapeutics, Inc. (HLS:TSE) last dividend payment?
Halo FAQ
The last dividend payment of HLS Therapeutics, Inc. (HLS:TSE) is CAD$0.05.
What is the franking level for HLS Therapeutics, Inc. (HLS:TSE)?
Halo FAQ
HLS Therapeutics, Inc. (HLS:TSE) has a franking level of 0.00%.
In which sector is HLS Therapeutics, Inc. (HLS:TSE) classified?
Halo FAQ
HLS Therapeutics, Inc. (HLS:TSE) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial